αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction
Synucleins are a vertebrate-specific family of abundant neuronal proteins. They comprise three closely related members, α-, β-, and γ-synuclein. α-Synuclein has been the focus of intense attention since mutations in it were identified as a cause for familial Parkinson's disease. Despite their d...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 107; no. 45; pp. 19573 - 19578 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
09.11.2010
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Synucleins are a vertebrate-specific family of abundant neuronal proteins. They comprise three closely related members, α-, β-, and γ-synuclein. α-Synuclein has been the focus of intense attention since mutations in it were identified as a cause for familial Parkinson's disease. Despite their disease relevance, the normal physiological function of synucleins has remained elusive. To address this, we generated and characterized αβγ-synuclein knockout mice, which lack all members of this protein family. Deletion of synucleins causes alterations in synaptic structure and transmission, age-dependent neuronal dysfunction, as well as diminished survival. Abrogation of synuclein expression decreased excitatory synapse size by ~30% both in vivo and in vitro, revealing that synucleins are important determinants of presynaptic terminal size. Young synuclein null mice show improved basic transmission, whereas older mice show a pronounced decrement. The late onset phenotypes in synuclein null mice were not due to a loss of synapses or neurons but rather reflect specific changes in synaptic protein composition and axonal structure. Our results demonstrate that synucleins contribute importantly to the long-term operation of the nervous system and that alterations in their physiological function could contribute to the development of Parkinson's disease. |
---|---|
Bibliography: | Edited* by Thomas C. Südhof, Stanford University School of Medicine, Palo Alto, CA, and approved October 6, 2010 (received for review April 13, 2010) Author contributions: N.T., P.E.C., V.L.B., and S.S.C. designed research; B.G.-H., M.P., M.M.-T., L.D., A.M.W., E.H.N., S.M., and S.S.C. performed research; V.L.B. contributed new reagents/analytic tools; B.G.-H., M.P., M.M.-T., L.D., A.M.W., E.H.N., S.M., and S.S.C. analyzed data; and B.G.-H. and S.S.C. wrote the paper. 1Present address: University of Utah School of Medicine, Salt Lake City, UT 84132. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1005005107 |